Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1539 of 6351
-
New cognitive rehab program aims to clear mental fog after mild brain injury
Symptom relief Recruiting nowMild traumatic brain injury (mTBI) affects millions of individuals worldwide every year. It has long been thought that the vast majority of individuals who sustain a mTBI experience natural recovery with little or no intervention and return to baseline functioning within days to …
Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Pregnancy exercise app aims to stop leaks and pelvic issues
Disease control Recruiting nowThe project seeks to investigate effectiveness of PFMT during pregnancy.
Sponsor: University of Southern Denmark • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
AI stethoscope screens thousands of kids for heart disease
Diagnosis CompletedThe goal of this observational diagnostic study is to evaluate whether an artificial intelligence (AI)-enabled smart stethoscope can accurately detect structural heart disease in school-aged children and adolescents (10-18 years) in Ruyang County, China. The main questions it ai…
Sponsor: Heart Health Research Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control Not yet recruitingThis is a randomized, double-blind, placebo-controlled multicenter clinical study to evaluate the efficacy, safety, and pharmacokinetics of SIM0278 in adult patients (18-75 years) with moderate to severe AD suitable for systemic therapy. Approximately 184 subjects with moderate …
Phase 2 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can immune therapy help rare muscle disorder?
Disease control Recruiting nowThis is a randomized, placebo-controlled, double blinded phase 2 exploratory clinical trial of intravenously administered pooled human immunoglobulin (IVIG) in anti-3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) immune mediated necrotizing myopathy (IMNM). Planned enrollment is…
Phase 2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Wellness devices show promise for long COVID relief
Symptom relief CompletedThe purpose of this study is to explore whether two general wellness products, alone or combined, can support individuals experiencing Long COVID symptoms. Both wellness products stimulate the vagus nerve - a nerve that helps regulate stress, relaxation, mood, breathing, heart ra…
Sponsor: Leidos Life Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Can a simple guide after hospital stay curb opioid relapse? philly study aims to find out
Knowledge-focused Recruiting nowPatient Navigation (PN) interventions following hospitalization can improve outcomes for people with opioid use disorder treatment. Delivering PN interventions on a wide scale requires many resources and coordination across institutions. This will use an evidence-based process to…
Sponsor: Friends Research Institute, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
New epilepsy drug vormatrigine tested for Long-Term safety in 700 adults
Disease control By invitation onlyOpen Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy
Phase 3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New combo targets tough colorectal cancer in Liver-Free patients
Disease control Recruiting nowThis is a prospective, randomized, open-label, multicenter phase II investigating the therapy of Fruquintinib in combination with Tislelizumab in patients with MSS/pMMR metastatic colorectal cancer without liver metastases.
Phase 2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New blood test aims to detect hidden infections in vulnerable patients
Diagnosis Recruiting nowThis clinical trial is designed to evaluate if adding the Karius Spectrum™ plasma test to usual care diagnostic tests, compared to usual care testing alone, among immunocompromised participants presenting with suspected infection in the outpatient setting leads to faster infectio…
Sponsor: Karius, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
Could a malaria vaccine ward off another deadly disease?
Prevention Recruiting nowThe goal of this observational study is to learn about the impact of malaria vaccination on the risk of invasive non-typhoidal Salmonella disease in children below the age of 5. Eligible participants residing in the Kisantu Health Zone (DRC) and presenting fever are enrolled in h…
Sponsor: International Vaccine Institute • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
Could fasting boost immunotherapy? new trial tests diet combo for lung cancer
Disease control Recruiting nowThe purpose of this study is to learn the effects of fasting on cancer cells while you get maintenance treatment.
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug aims to stop kidney disease relapses
Disease control Recruiting nowThis is a phase II/III multicenter, randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of BAT4406F injection in patients with Minimal Change Disease/Focal Segmental Glomerulosclerosis
Phase 2/3 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can a smartphone app lift depression in young cancer survivors?
Symptom relief Recruiting nowOur team has developed a digital intervention that aims to help adolescent and young adult cancer survivors (AYAs) manage symptoms of depression. This tool includes one psychoeducation component and four components that are based on evidence-based interventions for depression. Th…
Sponsor: East Carolina University • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New therapy targets depression rooted in childhood trauma
Symptom relief Recruiting nowThe RESPOND trial explores the link between early life adversity and later life depressive symptoms. The investigators have designed a new psychological therapy tailored to address the symptoms that can be caused by difficult experiences in early life. These symptoms include low …
Sponsor: St. Joseph's Healthcare Hamilton • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
New talk therapy aims to calm End-of-Life fears in advanced cancer patients
Symptom relief Recruiting nowThe psychological challenges faced by patients with incurable cancer and their caregivers include an uncertain future, fear of dying and uncontrollable suffering, grief, and loneliness. In a significant subgroup, this challenge is associated with significant fear and existential …
Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New targeted drug may improve lymphoma treatment
Disease control Recruiting nowThis study aims to explore a new treatment approach for patients with treatment-naive Marginal Zone Lymphoma (MZL). MZL is a type of slow-growing lymphoma that often affects older adults. The current standard treatment involves chemotherapy, but it can have significant side effec…
Phase 2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Shockwave therapy may crack tough heart artery plaque
Disease control OngoingThe goal of this clinical trial is to investigate whether the clinical outcomes of combined application of intravascular lithotripsy (IVL) following routine preconditioning are superior to those of routine preconditioning alone in patients with moderate-to-severe coronary artery …
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
AI spots hidden brain aneurysms in routine scans
Diagnosis OngoingThe goal of this clinical trial is to verify the opportunistic screening potential of the AI software for detection of brain unruptured intracranial aneurysms (UIA) on routinely performed brain NECT scans in a prospective setting in the Belgian population. The main question the …
Sponsor: Ziekenhuis Oost-Limburg • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Amniotic grafts show promise for chronic wounds in large Real-World study
Disease control OngoingThis retrospective multi-site observational cohort study uses electronic health records (EHR) from U.S. wound care centers to evaluate the effectiveness of four amniotic membrane allografts (Acesso DL, Acesso TL, Neostim DL, Neostim TL) when added to standard wound care for diabe…
Sponsor: Dynamic Medical Services dba Acesso Biologics • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC